Frank's international n.v. (FI)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13
Cash flows from operating activities
Net loss

-85,978

-168,093

-23,789

-15,160

-28,287

-15,898

-6,999

-25,763

-42,073

-109,140

2,296

-25,950

-26,663

-66,186

-42,198

-45,287

-2,408

6,768

24,088

28,853

46,401

51,461

67,440

50,049

60,362

76,448

59,467

141,870

73,045

Adjustments to reconcile net loss to cash from operating activities
Depreciation and amortization

19,718

22,163

21,482

23,913

25,242

27,132

26,998

28,862

28,300

29,402

30,650

30,951

31,099

29,937

26,545

28,283

29,450

28,219

29,032

27,710

24,001

23,699

23,254

21,895

21,193

21,488

19,887

19,068

17,783

Equity-based compensation expense

2,146

3,042

2,647

3,017

2,574

2,445

3,008

2,888

2,280

2,367

2,342

3,415

5,701

3,622

3,828

4,320

4,208

3,847

6,096

10,647

8,010

8,918

9,214

15,347

4,889

4,700

2,520

0

0

Goodwill impairment

57,146

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on asset impairments and retirements

20,187

-

-

-

66

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

ESPP expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

55

-

0

0

0

-

-

-

-

Amortization of deferred financing costs

97

97

97

90

87

58

0

0

0

0

21

41

205

41

41

41

41

41

41

41

41

0

63

76

96

86

43

0

0

Venezuelan currency devaluation charge

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

3,510

0

-1,755

Deferred tax provision (benefit)

-1,690

-3,160

185

84

3,618

-14,634

0

0

0

2,719

33,144

-9,260

-11,060

-1,764

-16,701

-5,768

-3,303

-8,955

4,096

3,947

5,780

-29,961

-1,055

1,495

1,526

-815

-1,605

-1,034

-167

Provision for bad debts

1,280

1,308

-112

66

19

91

27

-62

103

592

-13

462

-91

1,171

36

9,993

381

350

-457

289

46

-3,024

109

23

-245

765

8,029

2,414

1,343

Loss on disposal of assets

-60

-53

-603

-154

-227

-481

2,242

-217

-235

-46

829

-210

1,472

-2,212

46

279

770

517

1,392

-687

-184

-96

-280

-154

241

191

-125

39,709

-23

Changes in fair value of investments

-2,411

812

56

467

1,412

-2,494

878

608

-191

618

535

461

1,013

62

732

423

-94

995

-2,140

-317

721

680

-582

989

316

1,510

1,092

-25

1,314

Unrealized gain on derivative instruments

0

-571

553

-700

496

-56

-323

204

561

-585

681

-274

-456

232

-615

1,293

-974

210

0

0

0

-

-

-

-

-

-

-

-

Realized loss on sale of investment

-

-

-

-

-

-

-

-

-

0

0

0

-478

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Increase in value of life insurance policies

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-32

847

Other

381

956

193

-193

566

-843

0

0

0

689

-689

0

1,876

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities
Accounts receivable

16,129

-12,280

-24,206

-400

14,734

26,402

15,540

17,286

4,426

2,646

-30,614

-3,333

10,030

11,654

-13,276

-35,761

-33,005

-77,946

3,477

-52,503

-13,685

37,570

10,150

9,347

-13,718

24,128

-695

38,884

19,715

Inventories

1,855

-3,497

11,868

-1,760

4,083

-553

2,009

-1,008

2,469

-5,956

-519

-895

-4,732

-7,347

-8,654

-10,550

-828

-3,926

-20,077

-23,775

6,276

-7,608

-2,288

15,493

24,685

21,753

15,728

21,752

26,421

Other current assets

814

1,681

-474

-1,292

-771

-2,344

-195

-1,000

-1,042

-1,580

-3,995

-2,057

-1,045

1,951

-2,932

-2,869

-189

-5,180

-3,132

-1,911

-6,758

7,855

1,897

-99

-1,727

3,436

-3,833

3,207

-1,112

Other assets

-139

1,464

-68

-356

245

-54

120

-54

-270

1,274

-203

-1,198

-547

688

192

-201

13

1,146

-331

-83

-2,065

3,834

-659

-1,884

328

-317

1,181

685

-119

Accounts payable and accrued liabilities

-14,860

3,907

9,274

-3,934

-13,184

25,559

-57

-6,897

-3,295

7,464

3,910

-86

4,486

-47,542

2,640

696

-2,862

-4,197

-616

-299

2,077

2,084

2,496

-3,096

3,507

-4,281

-847

98

-248

Deferred revenue

67

435

88

0

22

-8

78

-14

-410

-4,334

-1,332

-3,991

-3,716

-10,180

-8,256

-16,067

-5,156

-801

902

-12,713

-5,861

-1,110

7,308

7,184

123

-2,443

5,077

22,110

14,693

Accrued expenses and other current liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-10,598

-11,492

-6,466

21,962

-1,137

-18,685

1,831

14,244

10,239

13,039

-4,607

-16,412

9,219

17,371

-12,922

Other non-current liabilities

-3,796

-150

-947

-17

611

-2,418

-316

-148

-96

-862

-201

-1,120

-2,263

-1,185

-10,035

-231

-2,029

953

-1,849

681

2,053

1,857

1,152

1,815

1,091

1,197

1,761

1,573

2,425

Net cash used in operating activities

-22,252

18,563

25,874

12,381

-29,770

2,750

2,468

-16,953

-20,909

189

32,052

1,968

-9,435

-38,677

-30,191

11,874

46,163

132,371

79,475

115,783

100,129

94,933

111,982

84,135

77,810

37,274

90,203

99,290

50,664

Cash flows from investing activities
Purchases of property, plant and equipment and intangibles

9,968

9,963

9,739

9,095

8,145

5,177

3,292

4,942

6,323

3,386

3,364

3,520

11,720

12,350

11,406

10,103

8,268

11,427

17,453

26,972

43,871

48,765

46,465

40,820

36,902

57,741

39,295

46,957

40,511

Proceeds from sale of assets

70

438

93

246

14

2,670

2,664

116

1,639

3,340

8,490

564

1,636

1,623

278

776

1,181

1,479

2,886

124

90

195

-1,836

2,099

390

488

218

50,204

49

Proceeds from sale of investments

0

0

15,000

19,200

12,539

75,891

10,988

25,977

30,969

41,800

0

8,600

2,899

0

11,101

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Purchase of investments

0

-182

119

15,093

5,092

17,029

24,732

15,851

26,428

62,284

60,646

59

59

82

83

102

736

-

-

-

-

-

-

-

-

-

-

-

-

Purchase of marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

94

0

0

0

0

0

1,539

626

163

694

330

Other

141

-

-

-

103

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Premiums on life insurance policies

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

14

-

-

-

0

0

-224

1,144

1,222

Net cash used in investing activities

-10,039

-9,855

5,235

-4,639

-787

19,618

-14,372

5,300

-143

-20,466

-55,584

5,585

-7,244

-161,553

-110

-9,429

-7,823

-10,723

-14,661

-105,510

-43,795

-48,570

-48,301

-38,721

-38,051

-57,879

-39,016

1,409

-42,014

Cash flows from financing activities
Repayments of borrowings

0

517

1,618

1,755

1,737

1,603

1,368

1,466

1,455

490

36

82

72

81

2,160

2,178

2,782

708

20

18

19

18

18

18

18

206

418,460

31,468

21,936

Proceeds from borrowings

-

-

-

-

-

-

-

-

-

-

-

-

4

45

62

160

96

151

0

0

0

-

-

-

-

-

-

-

-

Dividends paid on common stock

-

-

-

-

-

-

-

-

-

-270

16,998

16,723

16,703

16,680

15,491

23,542

23,300

23,271

23,268

23,155

23,150

23,141

23,141

11,515

11,514

11,514

0

0

0

Distribution to noncontrolling interest

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

3,015

5,012

0

11,060

11,497

20,982

9,095

10,246

17,549

4,675

11,496

0

0

0

Treasury shares withheld for taxes

1,056

12

332

1,542

1,452

135

284

182

1,035

629

23

447

1,802

218

1,650

812

584

138

3,826

497

36

647

4,154

0

0

-

-

-

-

Proceeds from the issuance of ESPP shares

552

0

1,060

0

692

0

753

1

561

12

-14

740

526

0

0

585

388

-3

290

0

0

-

-

-

-

-

-

-

-

Distributions to stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

83,068

22,299

Net cash used in financing activities

-1,521

-529

-890

-2,029

-2,497

-3,310

-1,012

-1,695

-1,929

-837

-17,071

-16,516

-18,047

-16,934

-19,834

-28,803

-31,194

-23,969

-37,884

-35,169

-44,187

-32,901

-37,559

-29,083

-16,207

-23,244

292,249

-114,536

-44,235

Effect of exchange rate changes on cash

9,327

-3,213

3,100

-40

-376

1,027

279

3,333

-1,255

791

-1,009

-27

-860

6,840

-1,386

-1,069

-707

-2,373

5,378

1,199

-3,059

8,544

-1,410

-553

-601

-726

79

-3,548

5,457

Net decrease in cash, cash equivalents and restricted cash

-24,485

4,966

33,319

5,673

-33,430

20,085

-12,637

-10,015

-24,236

-20,323

-41,612

-8,990

-35,586

-210,324

-51,521

-27,427

6,439

95,306

32,308

-23,697

9,088

20,966

24,712

15,778

22,951

-44,575

343,515

-17,385

-29,553

Effect of exchange rate changes on cash due to Venezuelan devaluation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

575

Non-cash transactions:
Change in accounts payable and accrued liabilities related to capital expenditures

-

-

-

-

-

-

-

-

-

-

1,082

471

2,430

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net transfers from inventory to property, plant and equipment

-

-

-

-

-

-

-

-

-

-

-990

-1,358

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-